Comparison of the Efficacy of Innovator Rituximab and its Biosimilars in Diffuse Large B Cell Lymphoma Patients: A Retrospective Analysis

Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma among adults, although it also affects the young and the elderly. DLBCL is treated with a chimeric monoclonal antibody against CD20, a B cell surface protein, named rituximab, in combination with a multidrug chemot...

Full description

Saved in:
Bibliographic Details
Published in:Indian J Hematol Blood Transfus
Main Authors: Bankar, Aniket, Korula, Anu, Abraham, Aby, Viswabandya, Auro, George, Biju, Srivastava, Alok, Mathews, Vikram
Format: Artigo
Language:Inglês
Published: Springer India 2019
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042466/
https://ncbi.nlm.nih.gov/pubmed/32174693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-019-01167-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items